(Q37330689)

19 August 2017

1 reference

title

Current control and treatment of multidrug-resistant Acinetobacter baumannii infections (English)

1 reference

19 August 2017

Acinetobacter baumannii

1 reference

inferred from title

multiple drug resistance

1 reference

2

Matthew E Falagas

1 reference

19 August 2017

Drosos E Karageorgopoulos

series ordinal

1

1 reference

19 August 2017

1 December 2008

1 reference

Lancet Infectious Diseases

19 August 2017

1 reference

19 August 2017

8

1 reference

19 August 2017

12

1 reference

19 August 2017

751-762

1 reference

An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii

19 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Antimicrobial resistance of Acinetobacter spp. in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (199

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

The distribution of Acinetobacter species in clinical culture materials.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Epidemiology and infection control implications of Acinetobacter spp. in Hong Kong

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Prevalence of Acinetobacter baumannii and other Acinetobacter spp. in faecal samples from non-hospitalised individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: risk factors and outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Multidrug-resistant Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Overview of nosocomial infections caused by gram-negative bacilli

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Community-acquired Acinetobacter infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Acinetobacter skin carriage among US army soldiers deployed in Iraq

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Acinetobacter baumannii: emergence and spread in Israeli hospitals 1997-2002.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Antimicrobial susceptibility among Acinetobacter calcoaceticus-baumannii complex and Enterobacteriaceae collected as part of the Tigecycline Evaluation and Surveillance Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Epidemiology of multiple Acinetobacter outbreaks in The Netherlands during the period 1999-2001.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Interinstitutional and intrainstitutional transmission of a strain of Acinetobacter baumannii detected by molecular analysis: comparison of pulsed-field gel electrophoresis and repetitive sequence-based polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Nosocomial colonization and infection with multiresistant Acinetobacter baumannii: outbreak delineation using DNA macrorestriction analysis and PCR-fingerprinting

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

AcinetobacterOutbreaks, 1977–2000

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

How long do nosocomial pathogens persist on inanimate surfaces? A systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Antibiotic resistance is a major risk factor for epidemic behavior of Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Biofilm formation in Acinetobacter baumannii: associated features and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Molecular and epidemiologic study of polyclonal outbreaks of multidrug-resistant Acinetobacter baumannii infection in an Israeli hospital.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Genotypic investigation of multidrug-resistant Acinetobacter baumannii infections in a medical intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Epidemiological significance of cutaneous, pharyngeal, and digestive tract colonization by multiresistant Acinetobacter baumannii in ICU patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

An outbreak due to multiresistant Acinetobacter baumannii in a burn unit: risk factors for acquisition and management

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Outbreak of multidrug-resistant Acinetobacter baumannii in a Belgian university hospital after transfer of patients from Greece

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Control of an outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus colonization and infection in an intensive care unit (ICU) without closing the ICU or placing patients in isolation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Considerations in Control and Treatment of Nosocomial Infections Due to Multidrug‐ResistantAcinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Concurrent outbreak of multidrug-resistant and susceptible subclones of Acinetobacter baumannii affecting different wards of a single hospital.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Role of environmental cleaning in controlling an outbreak of Acinetobacter baumannii on a neurosurgical intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Nosocomial outbreak of multi-resistant Acinetobacter sp. on an intensive care unit: possible association with ventilation equipment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Investigation of an outbreak of multidrug-resistant Acinetobacter baumannii in trauma intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Outbreak of nosocomial meningitis caused by Acinetobacter baumannii in neurosurgical patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Epidemiologic, clinical, and economic evaluation of an outbreak of clonal multidrug-resistant Acinetobacter baumannii infection in a surgical intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Carbapenem-resistant Acinetobacter and role of curtains in an outbreak in intensive care units

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Survival of Acinetobacter baumannii on bed rails during an outbreak and during sporadic cases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Eradication of multi-drug resistant Acinetobacter from an intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Healthcare-associated outbreak due to pan-drug resistant Acinetobacter baumannii in a surgical intensive care unit.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Environmental contamination during a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Investigation of an outbreak of multi-drug resistant Acinetobacter baumannii in an intensive care burns unit

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Persistent Acinetobacter baumannii? Look inside your medical equipment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

An outbreak of Acinetobacter respiratory tract infection resulting from incomplete disinfection of ventilatory equipment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Control of an outbreak of multi-drug-resistant Acinetobacter baumannii in an intensive care unit and a surgical ward.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Epidemic bacteremia due to Acinetobacter baumannii in five intensive care units

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Blood pressure cuffs as potential reservoirs of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

An outbreak of multidrug-resistant Acinetobacter baumannii associated with pulsatile lavage wound treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Bacteriological, clinical and epidemiological characteristics of hospital-acquired Acinetobacter baumannii infection in a teaching hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Nosocomial outbreak of multi-resistant Acinetobacter baumannii on a surgical ward: epidemiology and risk factors for acquisition

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Outbreak of Acinetobacter baumannii in an intensive care unit associated with tracheostomy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

An Outbreak of Multiresistant Acinetobacter baumanii in a University Hospital in São Paulo, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

An outbreak of Acinetobacter baumannii: the importance of cross-transmission

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

An outbreak of imipenem-resistant Acinetobacter baumannii in critically ill surgical patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Epidemiology and risk factors for colonization and infection by Acinetobacter baumannii in an ICU in Tunisia, where this pathogen is endemic

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Risk factors for an outbreak of multi-drug-resistant Acinetobacter nosocomial pneumonia among intubated patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Management of multidrug-resistant organisms in health care settings, 2006.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Emergence of resistant Acinetobacter baumannii in critically ill patients within an acute care teaching hospital and a long-term acute care hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Assessment of Acinetobacter baumannii susceptibility to antiseptics and disinfectants.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Low concentrations of commercial alcohol hand rubs facilitate growth of and secretion of extracellular proteins by multidrug-resistant strains of Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Infection control in long-term care facilities

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Comparison of mortality of patients with Acinetobacter baumannii bacteraemia receiving appropriate and inappropriate empirical therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

In vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii and Stenotrophomonas maltophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Efficacy of colistin versus beta-lactams, aminoglycosides, and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Colistin offers prolonged survival in experimental infection by multidrug-resistant Acinetobacter baumannii: the significance of co-administration of rifampicin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Intravenous Colistin as Therapy for Nosocomial Infections Caused by Multidrug‐Resistant Pseudomonas aeruginosa and Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin-meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Polymyxin B and doxycycline use in patients with multidrug-resistant Acinetobacter baumannii infections in the intensive care unit.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: clinical outcome and adverse events.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Polymyxin B nephrotoxicity and efficacy against nosocomial infections caused by multiresistant gram-negative bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Use of colistin in the treatment of multiple-drug-resistant gram-negative infections.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Successful treatment of multidrug-resistant Acinetobacter baumannii central nervous system infections with colistin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Post-surgical meningitis due to multiresistant Acinetobacter baumannii. Effective treatment with intravenous and/or intraventricular colistin and therapeutic dilemmas.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Toxicity of polymyxins: a systematic review of the evidence from old and recent studies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Nephrotoxicity of intravenous colistin: a prospective evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Toxicity after prolonged (more than four weeks) administration of intravenous colistin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Activity of colistin against heteroresistant Acinetobacter baumannii and emergence of resistance in an in vitro pharmacokinetic/pharmacodynamic model.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Ampicillin/sulbactam: current status in severe bacterial infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

In vitro and in vivo activity of meropenem and sulbactam against a multidrug-resistant Acinetobacter baumannii strain

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Comparison in a rat thigh abscess model of imipenem, meropenem and cefoperazone-sulbactam against Acinetobacter baumannii strains in terms of bactericidal efficacy and resistance selection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Comparison of efficacy of cefoperazone/sulbactam and imipenem/cilastatin for treatment of Acinetobacter bacteremia.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

High-dose ampicillin-sulbactam as an alternative treatment of late-onset VAP from multidrug-resistant Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Treatment of multidrug-resistant Acinetobacter baumannii meningitis with ampicillin/sulbactam

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Multidrug-resistant Acinetobacter baumannii bacteraemia: clinical features, antimicrobial therapy and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Imipenem, doxycycline and amikacin in monotherapy and in combination in Acinetobacter baumannii experimental pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Tetracyclines for treating multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

In vivo activity of levofloxacin alone or in combination with imipenem or amikacin in a mouse model of Acinetobacter baumannii pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Combination carbapenem-sulbactam therapy for critically ill patients with multidrug-resistant Acinetobacter baumannii bacteremia: four case reports and an in vitro combination synergy study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Treatment of pan-drug resistant Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Pharmacokinetic/pharmacodynamic assessment of the in-vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Evaluation of antibiotic combinations against multidrug-resistant Acinetobacter baumannii using the E-test.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

In-vitro activity of polymyxin B in combination with imipenem, rifampicin and azithromycin versus multidrug resistant strains of Acinetobacter baumannii producing OXA-23 carbapenemases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

In vitro activity of beta-lactam antimicrobial agents in combination with aztreonam tested against metallo-beta-lactamase-producing Pseudomonas aeruginosa and Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

In vitro double and triple synergistic activities of Polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Evaluation of the activities of two-drug combinations of rifampicin, polymyxin B and ampicillin/sulbactam against Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter spp.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970279-2

7 January 2021

10.1016/S1473-3099(08)70279-2

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

19022191